Condition
Trigeminal Neuropathy
Total Trials
4
Recruiting
0
Active
0
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results50% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Completed1
Unknown1
Withdrawn1
Terminated1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05914558Withdrawn
Comorbid Painful TMD Among Trigeminal Neuralgia
NCT05142228Phase 2TerminatedPrimary
Erenumab-aooe for the Management of Trigeminal Neuropathic Pain.
NCT04612855Completed
Post-traumatic Neuropathy of the Trigeminal Nerve
NCT03710967Not ApplicableUnknown
Bilateral TMS vs. Unilateral TMS
Showing all 4 trials